The iFuse Implant System comes with titanium implants coated with a porous plasma spray that acts as an interference surface fit, which helps to decrease implant motion.
The iFuse has a substantial thickness and sophisticated metallurgy, which provide immediate post-operative fixation, accomplishing the goal of traditional open SI Joint fusion through an MIS approach.
Si-Bone plans to introduce the iFuse Implant System in the EU at the upcoming Eurospine Meeting in Vienna.
Si-Bone president and CEO Jeff Dunn said that the iFuse Implant System provides spine surgeons with a unique minimally invasive surgical approach to SI joint fixation/fusion. The CE mark will allow the EU team to develop a presence in selected EU markets to address the needs of physicians committed to treating patients with SI joint problems.
“Si-Bone looks forward to entering these markets because we offer the only technology which provides an MIS solution to treat these SI joint conditions,” Dunn said.
